ORIGINAL RESEARCH
Published on 18 Aug 2026
Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development
doi 10.3389/fphar.2026.1808307
- 545 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Modulating Epithelial-Mesenchymal Transition within the Tumor Microenvironment for Targeted Cancer Therapy
Modulating Epithelial-Mesenchymal Transition within the Tumor Microenvironment for Targeted Cancer Therapy
1,580
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 17 Jun 2026
Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer
doi 10.3389/fphar.2026.1788376
- 1,678 views
REVIEW
Published on 08 May 2026
The central role of EMT in tumor progression: mechanistic drivers, biomarker discovery, and therapeutic horizons
doi 10.3389/fphar.2026.1820481
- 2,303 views
- 2 citations
ORIGINAL RESEARCH
Published on 02 Mar 2026
Celastrol increases anoikis sensitivity to suppress triple-negative breast cancer via EGFR pathway and p-EMT state regulation
doi 10.3389/fphar.2026.1747871
- 1,494 views
REVIEW
Published on 26 Feb 2026
Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies
doi 10.3389/fphar.2026.1761280
- 1,491 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: